Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label OvPlex. Show all posts
Showing posts with label OvPlex. Show all posts
Wednesday, February 15, 2012

media/financial: (OvPlex™) HealthLinx confirms potential of novel biomarker in predicting ovarian cancer outcome - Proactiveinvestors (AU)

›
HealthLinx confirms potential of novel biomarker in predicting ovarian cancer outcome
Friday, December 17, 2010

HealthLinx Releases Initial Results from First Stage of 1,150-Subject OvPlex Study | ProteoMonitor | Proteomics | GenomeWeb

›
Wednesday, December 15, 2010

HealthLinx reports solid data from OvPlex study - ovarian cancer, medical diagnostics - Australian Life Scientist

›
Thursday, September 09, 2010

media: Doctor ordered to keep silent on company's ovarian cancer test - Healthlinx/OvPlex/Professor Quinn

›
Sunday, July 04, 2010

Ovarian cancer test comes under fire (OvPlex/Healthlinx/Australia) media article

›
OvPlex also available (according to article) in Britain/Singapore
Friday, March 26, 2010

Arrayit Signs on Docro to Help Ovarian Cancer Diagnostic Gain FDA Clearance GenomeWeb

›
Vermillion's OVA1 became the first protein-based in vitro diagnostic multivariate index assay to receive FDA clearance [See PM 09/1...
Tuesday, February 23, 2010

Financial news: HealthLinx Ltd launches ovarian cancer OvPlex™ test into UK market

›
HealthLinx (ASX: HTX) has reported that UK distribution partner Intus Healthcare is targeting a significant share of the potential 750,000 a...
Friday, February 12, 2010

PharmaLive press release: Clinical Science to publish manuscript on HTX005 ovarian cancer biomarker 'OvPlex' (plus HTX005/AGR2)

›
Note: the abstract included here did not indicate the number of patients involved in the studies (see prior research articles) but accordin...